Here’s what you should know.
1. Ms. Protopapas has more than 20 years healthcare experience.
2. She currently serves as the president and CEO of Cambridge, Mass.-based Mersana Therapeutics.
3. Bioverative CEO John Cox said, “Anna brings a proven track record of leading and growing biopharmaceutical companies, which will be extremely valuable as we work to deliver on our vision of building Bioverativ into a great rare disease company focused on blood disorders.”
More articles on improving health:
Only 31% of patients support surgeons performing overlapping surgeries: 4 things to know
20 US regions with the most & least medical debt
10 things to know about Regent Surgical Health
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
